Urothelial damage results in compromised urothelial barrier function and leakage of urine causing frequent bladder infections. The urothelium exhibits one of the lowest turnover rates among mammalian epithelia under homeostatic conditions. To explore the bio-engineering possibility to restore the urothelial lining of the urinary tract, we aimed to establish in vitro culture and characterization of urothelial cells from human ureter biopsies. In vitro cultures of urothelial cells were characterized for CK7, CK20, Ki67, Ecadherin, AE1, Uroplakin III marker expression. When in vitro culture of urothelial cells was maintained in low calcium (0.09mM) conditions, cells in culture expressed CK7, AE1, Ki67, low expression of E-cadherin and negative for uroplakins III, CK20 markers. However, when urothelial cells were exposed to 2mM calcium concentration, in vitro grown urothelial cells showed positive expression for CK7, AE1, Uroplakin III, E-cadherin and mild expression of CK20, Ki67 markers. Cultured urothelial cells can respond to in vitro differentiation cues. These in vitro expanded urothelial cell cultures, optimized in serum-free cell culture media and systematically characterized urothelial cells may be a prelude to in vivo bio-engineering applications in planned mice models.
INTRODUCTION
Epithelial tissues are cell layers that line the cavities and surfaces of the body and also configure the interface with the external environment. It is essential to maintain the epithelial tissue homeostasis to sustain the integrity of these barriers. Urothelium lines the bladder and associated lower urinary tract, which is mainly composed of transitional epithelium. This functions as a permeability barrier to limit exposure of deeper tissues to urine collected in the bladder [1, 2] . In response to damage, urothelium converts from mitotically quiescent to a highly proliferative state to preserve the urinary tissue barrier [3] . The adult urothelium is a specialized multi-layered epithelial lining of the urinary bladder, ureter, and urethra, which provides a waterproof barrier to toxic metabolites in the urine. Multi-layered urothelium comprises three layers, namely basal, intermediate, and terminally differentiated superficial (umbrella) cell layer.
Urothelial damage triggers a rapid, regenerative response leading to self-repair and restitution of barrier integrity. Cells that make up the urothelium directs resident population of cells to respond towards the external cues by entering into migratory and proliferative modes. A typical human urothelial cell culture model system could help the experimental investigation of urothelial wound repair. Studies involving scratch wounding of confluent urothelial cell monolayers have been useful in identifying critical signaling pathways [4] [5] [6] [7] . Studies on the usage of adult stem cells to treat patients with severe burns and hematological diseases have been successful [5, 6] . However, such adult stem cells in human urothelium, displaying clonogenicity, self-renewal, and differentiation potential have not been elaborately described. Urothelial stem cells capable of regenerative potential were isolated from mice tissue, which was found to express sonic hedgehog and p63 proteins in the basal cell layers of the bladder urothelium [7, 8] . A recent report has also shown p63 expression in porcine urothelial and human urothelial cells [9] .
The mammalian ureter acts as a conduit between the kidney and urinary bladder for the flow of urine. Urinary bladder, ureter, and urethra contain a multi-layered epithelium, which is urothelium, surrounded by smooth muscle layer. It has a little cell turnover rate and high proliferative potential in response to injury. Currently, the urothelial defects are repaired by conventional reconstructive surgery using the patient's autologous genital tissue or buccal mucosal grafts. Non-urological grafts are prone to complications like urethral strictures or fistulae. Thus, there is a need for alternative methods to restore the urothelial lining of the urinary tract for the standard functions. With this background, we pursued to isolate, culture and characterize these cells for future urothelial transplantation experiments.
METHODS

Patient samples: Ethical Human Research Approval
Ethical approval for working with human biopsies was given by the Institutional Review Board (IRB) of the Christian Medical College Vellore India. Ureter samples (biological waste material) were procured from nephrectomy patients (who were undergoing routine treatments for their medical conditions) after obtaining written informed consent. Human urothelial cells were isolated from ureteral biopsies from consented donors undergoing open surgeries for non-malignant congenital anomalies.
Human Urothelial tissue collection and processing
Surgical samples of about 1-3 centimeters were harvested and collected aseptically in ice-cold Hanks balanced salt solution (HBSS) containing penicillin, streptomycin. A representative sample was fixed in 10% buffered formalin, and fixed tissue was processed for H & E and immunohistological evaluation. Another part of the tissue was used for in vitro urothelial cell culture establishment.
Immunohistological assessment
Tissue was fixed in 10% buffered formalin and embedded in paraffin wax. 5μM sections were cut and mounted on slides. Dewaxed sections were hydrated with decreasing concentration of alcohol and subjected to antigen retrieval by treating with 0.25% trypsin for 30 minutes. Blocked and permeabilized by 0.1% Triton X-100 + 2%BSA / PBS for 2 hours. Then the tissue section was incubated with primary antibody ( Human Urothelial Cell isolation and in vitro culture expansion As mentioned earlier in the method section, human urothelial cells were isolated from the ureters of patients undergoing nephrectomy for non-malignant or congenital anomalies. Primary human urothelial cell isolation was carried out as previously described by Southgate et al. [6] . The urinary tract biopsies were incubated for 16 hours at 4 0 C in HBSS buffer supplemented with 0.1% EDTA (Sigma, USA), 10mM HEPES (Invitrogen, USA) and aprotinin (1X, Roche, Germany). Using fine forceps, the tissue was mechanically scraped. Scraped tissue was incubated with 2mL collagenase IV (100 U/mL, Sigma, USA) at 37 0 C for 1 hour. Finally, cells were strained through a 100µm cell strainer (Falcon, BD, CH) before being seeded onto complete Keratinocyte serum-free (KSFM; Invitrogen, USA) culture media (Invitrogen, USA). Cells were plated on primary dish in KSFM with Bovine pituitary extract (BPE, Invitrogen, USA) 50mg/ml, Cholera toxin (CT, Sigma, USA) 30ng/ml, Epidermal growth factor (EGF, Invitrogen, USA) 5ng/ml, penicillin (100 U/ml; Invitrogen, USA), streptomycin (1mg/ml; Invitrogen, USA). Cultures were maintained in 5% CO 2 at 37 0 C humidified chamber. Culture media was changed alternate days (or when media became slightly acidic) and in vitro expanded cells were passaged at 80-90% of cell confluency. Based on the earlier study protocol by Southgate et al. for directing cells towards urothelial lineage differentiation; initially urothelial cells were maintained in KSFM with a low calcium concentration of 0.09mM till passage 4, and from fifth passage onwards, cells were exposed to an increased concentration of calcium (2mM) for 10 days for induced urothelial differentiation.
Flow cytometry
Third passage urothelial cells cultured in 0.09mM calcium were trypsinized and fixed with 4% Paraformaldehyde for 15 minutes. PBS wash followed by blocking and permeabilized with 0.1% Triton X-100 + 2%BSA / PBS for 20 minutes. Cells were incubated with primary antibody for 20 minutes on ice (Table 1) , PBS wash followed by the appropriate secondary antibody (Goat anti-mouse IgG conjugated to Alexa Fluor 488 or 594) for 20 minutes on ice. Finally, cells were washed with PBS and analyzed by flow cytometry in BD Aria III.
Cell cycle analysis
Urothelial cells were trypsinized at Passage 4 (P4) and fixed in 80% ethyl alcohol for 30 minutes. Cells were washed with PBS and incubated with 1μg/ml DAPI (4, 6 diamidino-2-Phenylindole, Invitrogen, USA)/0.1% Triton x-100/PBS for 30 minutes at room temperature. The cells were then washed with PBS and analyzed in BD FACS Calibur.
Immunofluorescence
The second passage (P2) and sixth Passage (p6) urothelial cells were grown on a coverslip in a 24 well plate. Cells were fixed in 4% Paraformaldehyde for 15 minutes and washed with PBS, blocking of non-specific antigens and then permeabilized in 0.1% Triton X-100/2% BSA/PBS for 2 hours at room temperature. It was then washed with PBS and incubated with primary antibody (shown in Table-1) for overnight at 4 0 C, followed by the appropriate secondary antibody (Goat anti-mouse IgG conjugated to Alexa Fluor 488 or 594) for 2 hours at room temperature.
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Further cells were washed and mounted with mounting media with DAPI (Vector Laboratories). Images were captured with a confocal microscope. 
RESULTS
In situ immunohistological analysis of ureter tissue biopsies showed location and presence of urothelial cells with positive expression of well-established urothelial characteristic markers: Ki67, a marker of mitotically active cells, was expressed throughout the urothelium (Figure 1e ) with the MIB1 antibody against the Ki67 cell cycle associated antigen suggesting that the majority of cells were in the active phase of cycling. In the same tissue sample, urothelial differentiation markers CK20 ( Figure 1c ) were expressed predominantly in the superficial layer indicating terminally differentiated umbrella cells. E-cadherin, which is a cell adhesion molecule was expressed at intercellular junctions at the external layer (Figure 1d ). Uroplakin III expression was present on the superficial layer with features of mature umbrella cells (Figure 1f ). Immunostaining of cytokeratin markers was expressed predominantly in all three layers of the urothelium CK7 (Figure 1b) . AE1 was expressed throughout the urothelium (Figure 1a ), which demonstrated positive staining for epithelial cell layer of Urothelium (Figure 1 
Urothelial cells in vitro cultures can be established from ureter-derived mucosa
Since donors 2 and 5 were younger, these two in vitro expanded urothelial cultures grew beyond the sixth passage before attaining senescence (as shown in Table 2 
. Human urothelial culture. a) First-passage cells (20X), b) Third passage cells (20X), c) Undifferentiated cells in 0.09mM calcium media (40X), d) Terminal differentiated cells were grown in 2mM calcium media, flattened round like bull's eye shaped "Umbrella cells" (40X).]
Flow cytometric phenotypic analysis of in vitro expanded urothelial cells showed typical urothelial marker expression Cytokeratin 20 and E-cadherin cell surface markers were expressed in mature umbrella cells around 14% and 18% respectively. Cytokeratin 7 and AE1 are epithelial markers of urothelium exhibiting 98% and 32% expression. Ki67 is a proliferative cell marker quantified at 89% expression; this shows that most of the cells were mitotically active. 86% of cells expressed uroplakins III (Figure 3 ) marker. Though urinary tract epithelium originated from mesoderm, mesenchymal markers CD73, CD90, CD105 elicited only 38%, 60%, and 5% expression, respectively (as shown in Figure 3 ).
[ 
. Urothelial cells grown in 0.09mM calcium exhibiting expression of epithelial markers a) AE1, b) CK7; c) cells were negative for CK20 marker, illustrating that cells were undifferentiated (top row). Urothelial cells exposed to 2mM calcium showed positive epithelial characteristics d) AE1, e) CK7 and f) CK20, indicating terminal cytodifferentiation of urothelial cells (bottom row).]
Similarly, E-Cadherin, Ki67 and Uroplakins III expression varied, when in vitro culture conditions were shifted from 0.09mM (Figure 6a 
. Cultured normal human urothelial cells grown in 0.09mM calcium exhibits negative staining for Ecadherin (a), but positive for Ki67 (b), suggesting that the majority of cells were in proliferative phase and cells were negative for uroplakins III (c) (top row). Urothelial cells grown in 2mM calcium showed positivity for E-cadherin (d), Ki67 (e), a cell cycle associated antigen in nuclei, suggesting that the majority of cultured cells were out of cell cycle, and Uroplakin (f), a mature urothelial marker (moderately positive for uroplakins) (bottom row).]
DISCUSSION
Stem cells are undifferentiated and none-lineage committed cells that undergo unlimited self-renewal and multilineage differentiation to become specialized cells. Emerging evidence supports the existence of normal urothelial stem cells, and initial characterization of these cells revealed that similar signaling pathways are activated during developmental lineage specification. The mammalian ureter contains a water-tight epithelium surrounded by smooth muscle. Thus, in the urothelial tissue engineering approach, constructing epithelial tissue structure is the experimental cell biology outcome of the interactions between large numbers of individual cells transplanted with suitable scaffold in a model system. The harnessing of autologous urothelial stem cells and their natural matrix-associated factors may be useful in enhancing the integration of synthetic and other natural biomaterials in the context of urothelial reconstruction.
In this study biopsy specimens were taken from patients and cultured in vitro for establishing a proof-of-concept protocol for in vitro expansion of urothelial cells, their phenotypic characterization, cell cycle status and apoptosis pattern. These in vitro cultured cells will form the basis for testing well characterized urothelial progenitor cells in the in vivo experiments using NSG mice models. The growth rate of primary culture established was relatively slow, taking 4 to 5 weeks to reach confluence. Biopsy samples were taken from adults (age range 18 to 62). Samples JSCRT Volume-2 | Issue-1 August, 2018 collected from younger patients had better urothelial cell growth in culture than samples collected from older patients. Other studies have demonstrated that age factor influenced the rate of urothelial cell growth [4, 5, 6] .
The cytokeratin expression is indicative of epithelial derivation. CK7, CK18, and CK19 are the markers expressed throughout all layers in normal urothelium [7] . Available literature towards urothelium basal layer characterization have shown that urothelium cells were expressing phenotypic marker CK5 and CK17, but they did not express phenotypic marker CK20, which is generally associated with differentiated superficial cells [7, 8, 9] . The urothelium or transitional epithelium of the urinary tract shows alterations in the expression and configuration of cytokeratin isotypes associated with stratification and differentiation. Because the study by Harnden P et al. has shown that in vitro expanded urothelial cells were also expressing a positive marker for cytokeratin CK7, CK8, CK17, CK18, and CK19 [10] . The epithelial origin and terminal differentiation status were evaluated by immunostaining with cytokeratin AE1, CK7, and CK20.
In general, normal urothelium shows slow turnover. In this study, tissue sections, immunolabeled for the nuclear ki67 antigen, demonstrated that the majority of urothelial cells were in the cycling phase ( Figure 1 ). However, urothelium possesses high proliferative potential in response to damage [8] and also expanded in-vitro cells typically express the Ki67 antigen in our study ( Figure 6 ).
Normal urothelium expresses a number of cell adhesion molecules, which plays a vital role in cell-cell and cellmatrix interactions, like integrins and E-cadherin [10, 13] . Normal human urothelial cells in culture do not exhibit terminal differentiation-associated antigens, but on increasing the extracellular calcium concentration from 0.09mM to 2mM changes in cell phenotype, upregulation of E-cadherin, integrin adhesion molecules, and cellular stratification were observed.
Further, we evaluated, if in vitro cultured urothelial cells have the potential to differentiate into superficial mature umbrella cells. Umbrella cells create a surface layer of the urothelium, which is generally in constant contact with urine extracts. Uroplakins are the primarily responsible molecules for the urothelial barrier function in the urothelial cells by constructing protein-aggregates thus obstructing the urine from inflowing into surrounding tissues. Urothelial barrier protein plaques are mainly constituted by four proteins of the uroplakin family, composed of pairs of uroplakin-1a with uroplakin-2 and uroplakin-1b with uroplakin-3. Uroplakin III is native to urothelium but in our study primary cultures of human urothelium did not express uroplakins III as reported in the literature [14, 15, 16] , maybe because extrinsic in vitro culture conditions might have downregulated the expression since differentiated urothelial cells did show the uroplakins III expression in these culture conditions. Superficial umbrella cells are located on the apical surface of the urothelium, which is covered by protein plaques (asymmetric unit membranes of Uroplakin). This integral membrane protein synthesized by mammalian urothelia as their significant products of differentiation [17, 18] . In our study, the lack of expression of the uroplakins protein in early passages could be because cultured cells were not in a phase of terminal differentiation. However, on induction with 2mM calcium and in later passages, the cells expressed uroplakin proteins, which make up the specialized AUM plaques of umbrella cells. The markers CD73, CD105, CD90, and keratin, were selected for this study as they were previously used to characterize human urothelium [19] .
The biological utility and attributes of tissue-derived acellular biological scaffolds have been documented earlier in the literature. However, there is a lack of understanding about the molecular and cellular mechanisms that facilitate the seamless integration of biological scaffolds with in vitro expanded urothelial cells following implantation. It is evident and expected that surgical implantation of any biomaterial would initiate an innate immunological response: the intensity, duration, and outcome of which will be dependent upon the nature of the JSCRT Volume-2 | Issue-1 August, 2018
biomaterial and transplanted cells. Any urothelial bioengineering technique that requires the ingrowth of endogenous epithelial cells and fibroblast cells using acellular matrix is unlikely to apply to an extensive stricture with a poorly vascularized graft bed.
One of the common problem encountered in urological practice is repeated catheter insertion may cause damage to the urethral mucosa, which over time develops into a progressive narrowing of the lumen because of fibrotic ingrowth, preventing the free flow of urine. Tissue engineering using biocompatible materials incorporating cultured urothelial cells could be a possible strategy to address this distressing problem. Future research should be a focus on the development of stem cells seeded biologically compatible extracellular matrices that can be employed for long strictures with Stem cells-derived biological factors containing most of the cellular components available for maintaining the well-vascularized graft bed.
